When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SLGL - Sol-Gel jumps on FDA acceptance of Epsolay NDA
Sol-Gel Technologies Ltd.
The FDA accepts Sol-Gel Technologies' (NASDAQ:SLGL) New Drug Application (NDA) seeking approval of topical cream Epsolay (benzoyl peroxide) for the treatment of inflammatory lesions of rosacea, characterized by redness and often small, red, pus-filled bumps on the face.
More news on: Sol-Gel Technologies Ltd., Healthcare stocks news, Stocks on the move,